NDC 71335-1455

Lorazepam

Lorazepam

Lorazepam is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Bryant Ranch Prepack. The primary component is Lorazepam.

Product ID71335-1455_26d9a35d-15e4-4d88-ae57-11a0c3432dde
NDC71335-1455
Product TypeHuman Prescription Drug
Proprietary NameLorazepam
Generic NameLorazepam
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2017-03-24
Marketing CategoryANDA / ANDA
Application NumberANDA203572
Labeler NameBryant Ranch Prepack
Substance NameLORAZEPAM
Active Ingredient Strength1 mg/1
Pharm ClassesBenzodiazepine [EPC],Benzodiazepines [CS]
DEA ScheduleCIV
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 71335-1455-1

30 TABLET in 1 BOTTLE (71335-1455-1)
Marketing Start Date2020-01-02
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 71335-1455-3 [71335145503]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA203572
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-01-02

NDC 71335-1455-1 [71335145501]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA203572
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-01-02

NDC 71335-1455-8 [71335145508]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA203572
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-01-02

NDC 71335-1455-6 [71335145506]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA203572
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-01-02

NDC 71335-1455-2 [71335145502]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA203572
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-01-02

NDC 71335-1455-4 [71335145504]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA203572
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-01-02

NDC 71335-1455-9 [71335145509]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA203572
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-01-02

NDC 71335-1455-7 [71335145507]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA203572
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-01-02

NDC 71335-1455-5 [71335145505]

Lorazepam TABLET
Marketing CategoryANDA
Application NumberANDA203572
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-01-02

Drug Details

Active Ingredients

IngredientStrength
LORAZEPAM.5 mg/1

Pharmacological Class

  • Benzodiazepine [EPC]
  • Benzodiazepines [CS]

NDC Crossover Matching brand name "Lorazepam" or generic name "Lorazepam"

NDCBrand NameGeneric Name
0054-3532LorazepamLorazepam
0093-3425LorazepamLorazepam
0093-3426LorazepamLorazepam
0093-3427LorazepamLorazepam
0121-0770LorazepamLorazepam
67544-982LorazepamLorazepam
0409-6779LorazepamLorazepam
0409-6778LorazepamLorazepam
0409-6780LorazepamLorazepam
68071-3010LorazepamLorazepam
68071-3227LorazepamLorazepam
68071-3121LorazepamLorazepam
68071-3242LorazepamLorazepam
68071-3096LorazepamLorazepam
68084-736LorazepamLorazepam
68084-742LorazepamLorazepam
68084-754LorazepamLorazepam
68788-0241LorazepamLorazepam
68788-9511LorazepamLorazepam
68788-7355LorazepamLorazepam
68788-7411LorazepamLorazepam
68788-9839LorazepamLorazepam
68788-9258LorazepamLorazepam
68788-9840LorazepamLorazepam
68788-9982LorazepamLorazepam
69315-904LorazepamLorazepam
69315-906LorazepamLorazepam
69315-905LorazepamLorazepam
0591-0240LorazepamLorazepam
0591-0241LorazepamLorazepam
0591-0242LorazepamLorazepam
70518-0155LorazepamLorazepam
70518-0486LorazepamLorazepam
70518-0275LorazepamLorazepam
70518-0156LorazepamLorazepam
70518-0445LorazepamLorazepam
70518-1045LorazepamLorazepam
70518-1431LorazepamLorazepam
70518-1520LorazepamLorazepam
70518-1313LorazepamLorazepam
70518-1679LorazepamLorazepam
70518-1255LorazepamLorazepam
0603-4246LorazepamLorazepam
71205-200LorazepamLorazepam
71205-235LorazepamLorazepam
71205-228LorazepamLorazepam
71205-166LorazepamLorazepam
71335-0277LorazepamLorazepam
71335-0655LorazepamLorazepam
71335-0204LorazepamLorazepam

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.